ArticleDiabetes & metabolism journal2022

A 4-Week, Two-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of EOPatch in Well-Controlled Type 1 Diabetes Mellitus.

Jiyun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.